Issue 31 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

31

August 05, 2005Aug 05, 2005

Free

DOWNLOAD THE PDF

An “insurgency” targets randomized trials, demands access to investigational drugs

By Paul Goldberg

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

Critics of FDA misunderstand Bayesian analysis, statisticians say.

Abigail Alliance says statisticians usurped control of oncology. Milken’s optimism fuels the movement.

Gottlieb questions ODAC’s independence.

Recent Issues

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026

Volume 52 | Issue 27 - July 10, 2026